ACESO LIFE SCI (00474): Completion of loan agreement refinancing arrangement.
Sinomab Life Sciences Technology (00474) announced the refinancing arrangement related to the 2018 financing agreement. By 2025...
ACESO LIFE SCI (00474) announced the refinancing arrangement for the 2018 financing agreement. All conditions precedent under the 2025 loan agreement have been met, and completion of delivery was on September 26, 2025. With the completion of this delivery, the company has been provided with a total financing amount of approximately 87.3 million, of which approximately 70.3 million has been drawn down today to fully repay the UK loans and related transaction costs. The remaining 17 million will be used for capital expenditures for the company's UK properties over the next one to two years. The company will begin planning for a large-scale renovation project on its UK properties, including upgrading its main facilities and ancillary facilities, in order to increase rental income and capital value of the UK properties.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


